This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Clovis Oncology 대차 대조표 상태
재무 상태 기준 확인 0/6
Clovis Oncology has a total shareholder equity of $-417.9M and total debt of $660.4M, which brings its debt-to-equity ratio to -158%. Its total assets and total liabilities are $346.8M and $764.7M respectively.
주요 정보
-158.0%
부채 비율
US$660.38m
부채
| 이자 보상 비율 | n/a |
| 현금 | US$58.32m |
| 주식 | -US$417.89m |
| 총 부채 | US$764.66m |
| 총 자산 | US$346.78m |
최근 재무 상태 업데이트
Recent updates
재무 상태 분석
단기부채: C6O has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: C6O has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: C6O has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: C6O's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: Insufficient data to determine if C6O has enough cash runway based on its current free cash flow.
예측 현금 활주로: Insufficient data to determine if C6O has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.